Relevance of HLA compatibility in living donor liver transplantation: The double-edged sword associated with the patient outcome

Clinical Transplantation

Volumn 26, Issue 5, 2012, Pages

  Uchiyama, Hideaki ^a   Kayashima, Hiroto ^a   Matono, Rumi ^a   Shirabe, Ken ^a   Yoshizumi, Tomoharu ^a   Ikegami, Toru ^a   Soejima, Yuji ^a   Matsuura, Toshiharu ^a   Taguchi, Tomoaki ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Donor selection; Graft failure; Graft versus host disease; Liver transplantation; Living donor transplantation

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY COMPLEX; HUMAN; INFANT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; INFANT; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 84867601247     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12019     Document Type: Article

References (33)

1. Sanfilippo F, Vaughn WK, Spees EK, Light JA, LeFor WM. Benefits of HLA-A and HLA-B matching on graft and patient outcome after cadaveric-donor renal transplantation. N Engl J Med 1984: 311: 358.
2. Opelz G, Wujciak T, Döhler B, Scherer S, Mytilineos J. HLA compatibility and organ transplant survival. Collaborative Transplant Study. Rev Immunogenet 1999: 1: 334.
3. Quantz MA, Bennett LE, Meyer DM, Novick RJ. Does human leukocyte antigen matching influence the outcome of lung transplantation? An analysis of 3, 549 lung transplantations. J Heart Lung Transplant 2000: 19: 473.
4. Navarro V, Herrine S, Katopes C, Colombe B, Spain CV. The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database. Liver Transpl 2006: 12: 652.
5. Donaldson P, Underhill J, Doherty D et al. Influence of human leukocytes antigen matching on liver allograft survival and rejection: "the dualistic effect." Hepatology 1993: 17: 1008.
6. Markus BH, Duquesnoy RJ, Gordon RD et al. Histocompatibility and liver transplant outcome: does HLA exert a dualistic effect? Transplantation 1988: 46: 372.
7. Nikaein A, Backman L, Jennings L et al. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and crossmatching. Transplantation 1994: 58: 786.
8. Jakab SS, Navarro VJ, Colombe BW, Daskalakis C, Herrine SK, Rossi S. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database. Liver Transpl 2007: 13: 1405.
9. Sugawara Y, Makuuchi M, Kaneko J, Saiura A, Imamura H, Kokudo N. Risk factors for acute rejection in living donor liver transplantation. Clin Transplant 2003: 17: 347.
10. Suehiro T, Shimada M, Kishikawa K et al. Influence of HLA compatibility and lymphocyte cross-matching on acute cellular rejection following living donor adult liver transplantation. Liver Int 2005: 25: 1182.
11. Domiati-Saad R, Klintmalm GB, Netto G, Agura ED, Chinnakotla S, Smith DM. Acute graft versus host disease after liver transplantation: pattern of lymphocyte chimerism. Am J Transplant 2005: 5: 2968.
12. Patel KK, Patel AK, Ranjan RR, Shah AP. Transfusion associated graft versus host disease following whole blood transfusion from an unrelated donor in an immunocompetent patient. Indian J Hematol Blood Transfus 2010: 26: 92.
13. Oertel M, Kohlhaw K, Diepolder HM et al. Alloreactivity of natural killer cells in allogeneic liver transplantation. Transplantation 2001: 72: 116.
14. Dyer PA, Jawaheer D, Ollier B, Poulton K, Sinnott P, Thomson W. HLA allele detection using molecular techniques. Dis Markers 1993: 11: 145.
15. Williams F, Mawhinney H, Middleton D. Application of an HLA-B PCR-SSOP typing method to a bone marrow donor registry. Bone Marrow Transplant 1997: 19: 205.
16. Urata K, Kawasaki S, Matsunami H et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology 1995: 21: 1317.
17. Taketomi A, Kayashima H, Soejima Y et al. Donor risk in adult-to-adult living donor liver transplantation: impact of left lobe graft. Transplantation 2009: 87: 445.
18. The Japanese Liver Transplantation Society. Liver transplantation in Japan - registry by the Japanese Liver Transplantation Society. Ishoku 2010: 45: 621 [Japanese].
19. Desai M, Neuberger J. Chronic liver allograft dysfunction. Transplant Proc 2009: 41: 773.
20. Chinnakotla S, Smith DM, Domiati-Saad R et al. Acute graft-versus-host disease after liver transplantation: role of withdrawal of immunosuppression in therapeutic management. Liver Transpl 2007: 13: 157.
21. Taylor AL, Gibbs P, Bradley JA. Acute graft versus host disease following liver transplantation: the enemy within. Am J Transplant 2004: 4: 466.
22. Perri R, Assi M, Talwalkar J et al. Graft vs. host disease after liver transplantation: a new approach is needed. Liver Transpl 2007: 13: 1092.
23. Soejima Y, Shimada M, Suehiro T et al. Graft-versus-host disease following living donor liver transplantation. Liver Transpl 2004: 10: 460.
24. Lan X, Zhang MM, Pu CL et al. Impact of human leukocyte antigen mismatching on outcomes of liver transplantation: a meta-analysis. World J Gastroenterol 2010: 16: 3457.
25. Adams D. Immunological aspects of clinical liver transplantation. Immunol Lett 1991: 29: 69.
26. Langrehr JM, Puhl G, Bahra M et al. Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation. Liver Transpl 2006: 12: 644.
27. Mañez R, Mateo R, Tabasco J, Kusne S, Starzl TE, Duquesnoy RJ. The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation. Transplantation 1995: 59: 640.
28. Takeishi K, Shirabe K, Toshima T et al. De novo autoimmune hepatitis subsequent to switching from type 2b to type 2a alpha-pegylated interferon treatment for recurrent hepatitis C after liver transplantation: report of a case. Surg Today 2011: 41: 1016.
29. Norris S, Collins C, Doherty DG et al. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J Hepatol 1998: 28: 84.
30. Kamei H, Oike F, Fujimoto Y, Yamamoto H, Tanaka K, Kiuchi T. Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching. Liver Transpl 2006: 12: 140.
31. Nemoto T, Kubota K, Kita J et al. Unusual onset of chronic graft-versus-host disease after adult living-related liver transplantation from a homozygous donor. Transplantation 2003: 75: 733.
32. Kiuchi T, Harada H, Matsukawa H et al. One-way donor-recipient HLA-matching as a risk factor for graft-versus-host disease in living-related liver transplantation. Transpl Int 1998: 11(Suppl 1): S383.
33. Shimizu T, Hayashi M, Inoue Y et al. Acute graft-versus-host disease after living donor liver transplantation with donor-dominant one-way human leukocyte antigen matching at two loci. Transplantation 2010: 89: 1164.